Seqens
FranceEntry
2021
Hold
5yr
Status
Active
Who owns Seqens?
Seqens is currently owned by Eurazeo through Nov Sante Actions Non Cotees (2020 vintage), since 2021. Across its history, Seqens has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
EurazeoNov Sante Actions Non Cotees · 2020 · Healthcare
6 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Merieux Equity Partners, Ardian, Societe Generale Capital Partenaires and Eurazeo since 2016.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected · 1 lender on file
Active
Co-held by Merieux Equity Partners, Ardian, Societe Generale Capital Partenaires and Eurazeo since 2016.
Co-invest · 4 holders · 1 lender · 2016 · present
Merieux Equity PartnersActive
2016 · present(10yr) · Mérieux Participations 2 · 2014 · Buyout
ArdianActive
2016 · present(10yr) · Ardian Co-Investment Fund IV · 2015 · Buyout
EurazeoActive
2021 · present(5yr) · Nov Sante Actions Non Cotees · 2020 · Healthcare
CIC Private DebtLender
2021 · present(5yr) · CM-CIC Debt Fund 3 · 2019 · Private Debt
More from Nov Sante Actions Non Cotees
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
US
Track Seqens
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Seqens?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Seqens.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue